Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Consistently High 5.5-Year Progression-Free Survival (PFS) Rates in Patients with and without Bulky Baseline Lymphadenopathy ≥5 Cm Are Associated with High Undetectable Minimal Residual Disease (uMRD4) Rates after First-Line Treatment with Fixed-Duration Ibrutinib + Venetoclax for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) in the Phase 2 CAPTIVATE Study

Blood (2024) 144 (Supplement 1): 1869.

https://doi.org/10.1182/blood-2024-200936

Published: 2024

Journal Articles

Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up

Jan A. Burger, Neil E. Kay, John N. Allan, Paul M Barr, Jacqueline C. Barrientos, Carolyn Owen, Victoria Wang, Hsin-Hui Huang, Lynne Neumayr, Christopher Abbazio, Gabriel S. Krigsfeld, Sneh Mody, Paolo Ghia, Tait D. Shanafelt

Blood (2024) 144 (Supplement 1): 4615.

https://doi.org/10.1182/blood-2024-194382

Published: 2024

Journal Articles

Iron Level and Monocyte Morphology Predict TLR4 Expression and Reactive Oxygen Species Production Which Influences Chronic Inflammation in β-Thalassemia

Patrick B. Walter, PhD, Nick Slater, BS, Paul Harmatz, MD, Annie Higa, BS, Vivian Ng, BS, Marcels Weyhmiller, Patricia Evans, PhD, John B Porter, Nancy Sweeters, Jackson Price, BS, David Killilea, PhD, Lynne Neumayr, MD, Ashutosh Lal, MD, Elliott Vichinsky, MD

Blood (2015) 126 (23): 950.

https://doi.org/10.1182/blood.V126.23.950.950

Published: 2015

Journal Articles

Transfusion Complications in Thalassemia: A Report From the Centers for Disease Control and Prevention (CDC)

Elliott Vichinsky, MD, Lynne Neumayr, MD, Sean Trimble, MPH, Alexis A. Thompson, MD, MPH, Patricia Giardina, MD, Alan R. Cohen, MD, Thomas D. Coates, MD, Ellis J. Neufeld, MD, PhD, Althea M Grant, MPH, PhD, Jeanne Boudreaux, MD

Blood (2011) 118 (21): 340.

https://doi.org/10.1182/blood.V118.21.340.340

Published: 2011

Journal Articles

A Phase 2 Clinical Study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a Fetal Hemoglobin Inducer, in Patients with Sickle Cell Disease

Abdullah Kutlar, MD, Adlette Inati, MD, Ali T Taher, MD, Amal El-Beshlawy, MD, Marvin Reid, PhD, Miguel R. Abboud, MD, Hedy Smith, MD, PhD, Kenneth I. Ataga, MD, George R. Buchanan, MD, Punam Malik, MD, Nebu Koshy, MD, Lynne Neumayr, MD, Maria Aiello, MA, Elsa Johnson, MBA, J Michael White, PhD, Richard G. Ghalie, MD

Blood (2011) 118 (21): 1066.

https://doi.org/10.1182/blood.V118.21.1066.1066

Published: 2011

Journal Articles

Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia

Abdullah Kutlar, MD, Kenneth I. Ataga, MD, Marvin Reid, PhD, Loray A Blair-Britt, MD, Elliott Vichinsky, MD, Lynne Neumayr, MD, Richard J. Labotka, MD, MS, Jonathan Glass, MD, FACP, Andrea Small-WIlliams, MBBS, DM(HAEM), Jeffrey Keefer, MD, PhD, Ling Shen, MD, Michael S Boosalis, PhD, Audrey Thomson, BSc, Patrick Bobbitt, BS, Wayne Wallis, MD, Elsa Johnson, MBA, Ronald J Berenson, MD, Susan P Perrine, MD

Blood (2010) 116 (21): 943.

https://doi.org/10.1182/blood.V116.21.943.943

Published: 2010

Journal Articles

A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease

Blood (2010) 116 (21): 3221.

https://doi.org/10.1182/blood.V116.21.3221.3221

Published: 2010

Journal Articles

Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia

Ashutosh Lal, MD, Nancy Sweeters, PNP, Vivian Ng, Drucilla Foote, PNP, Patricia Evans, PhD, Lynne Neumayr, MD, Gregory Kurio, MD, Paul Harmatz, MD, John B. Porter, MD, Elliott Vichinsky, MD

Blood (2010) 116 (21): 4269.

https://doi.org/10.1182/blood.V116.21.4269.4269

Published: 2010

Journal Articles

Emergency Room Utilization by California Sickle Cell Patients During Pediatric to Adult Care Transition

Susan Paulukonis, MA, MPH, Lynne Neumayr, MD, Thomas D. Coates, MD, Elliott Vichinsky, MD, Lisa Feuchtbaum, MPH, DrPH

Blood (2010) 116 (21): 254.

https://doi.org/10.1182/blood.V116.21.254.254

Published: 2010

Journal Articles

A New Method of Hip Coring Decompression for the Treatment of Femoral Avascular Necrosis In Sickle Cell Disease: Perioperative Safety and Preliminary Efficacy Data

Rakesh Donthineni, MD, Janice Earl, FNP, Lynne Neumayr, MD, Robert W Hagar, MD, Keith C. Quirolo, MD, Christine Aguilar, MD, Elliott Vichinsky, MD

Blood (2010) 116 (21): 264.

https://doi.org/10.1182/blood.V116.21.264.264

Published: 2010

Journal Articles

Improved Engraftment without Graft-Versus-Host Disease After MHC-Mismatched Cord Blood Transplantation with Photochemically Treated Donor Lymphocytes.

Bindu Kanathezhath, MD, Myra Mizokami, MD, PhD, Lynne Neumayr, M.D., Hua Guo, MD, Mark C. Walters, MD, Frans A. Kuypers, PhD

Blood (2009) 114 (22): 2425.

https://doi.org/10.1182/blood.V114.22.2425.2425

Published: 2009

Journal Articles

Rate of Packed Red Blood Cell Transfusion in Pediatric Patients with Severe Chronic Anemia and Normal Cardiopulmonary Status: How Slow Is Truly Necessary?.

Anurag K. Agrawal, M.D., Edmund Hsu, Lynne Neumayr, M.D., Keith C. Quirolo, M.D., Heidi R. Flori, M.D.

Blood (2009) 114 (22): 3155.

https://doi.org/10.1182/blood.V114.22.3155.3155

Published: 2009

Journal Articles

Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia.

Ashutosh Lal, MD, Nancy Sweeters, RN, PNP, Matt Herz, Dru Foote, RN, PNP, Lynne Neumayr, MD, Greg Kurio, MD, Paul R Harmatz, MD, Elliott P Vichinsky, MD

Blood (2009) 114 (22): 2021.

https://doi.org/10.1182/blood.V114.22.2021.2021

Published: 2009

Journal Articles

Prolonged QTc in Sickle Cell Disease: A Potential Risk Factor for Early Death?

Sean Lindstedt, Lynne Neumayr, M.D., Gregory Kurio, M.D., Claudia Morris, M.D., Shanda Robertson, Ellen Fung, PhD, Paul Harmatz, M.D., John C Wood, MD, PhD, Elliott P. Vichinsky, M.D.

Blood (2008) 112 (11): 2476.

https://doi.org/10.1182/blood.V112.11.2476.2476

Published: 2008

Journal Articles

Left Ventricular Dysfunction in Chronically Transused Patients with Sickle Cell Anemia and Thalassemia.

Lynne Neumayr, MD, Ellen Fung, PhD, Paul Harmatz, MD, Ellen Butensky, PhD, John Wood, MD, Claudia Morris, MD, Shanda Robertson, BS, Meredith Milet, MS, Elliott Vichinsky, MD

Blood (2006) 108 (11): 3745.

https://doi.org/10.1182/blood.V108.11.3745.3745

Published: 2006

Journal Articles

MRI Assessment of Pituitary Iron and Volume in Thalassemia, and Relation to Hypothalamic-Pituitary-Gonadal Axis Function (HPG): A Feasibility Study.

Zhiyue J. Wang, PhD, Roland Fischer, PhD, Ellen Butensky, PhD, PNP, Lynne Neumayr, MD, Sylvia Titi Singer, MD, Phillip Lee, MD, Zili Chu, PhD, Jill V. Hunter, MD, John Firebaugh, Elliott Vichinsky, MD, Paul Harmatz, MD

Blood (2006) 108 (11): 1778.

https://doi.org/10.1182/blood.V108.11.1778.1778

Published: 2006

Journal Articles

Reversive Loss of Pulmonary Function Induced by Acute Chest Syndrome: A Report from the National Acute Chest Syndrome Study Group (NACSG).

Blood (2005) 106 (11): 315.

https://doi.org/10.1182/blood.V106.11.315.315

Published: 2005

Journal Articles

Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 2 Year Follow-Up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression.

Blood (2004) 104 (11): 1685.

https://doi.org/10.1182/blood.V104.11.1685.1685

Published: 2004

Journal Articles

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy

Paul Harmatz, Ellen Butensky, Keith Quirolo, Roger Williams, Linda Ferrell, Thomas Moyer, Daniel Golden, Lynne Neumayr, Elliott Vichinsky

Blood (2000) 96 (1): 76–79.

https://doi.org/10.1182/blood.V96.1.76

Published: 2000

NARROW

Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up

Iron Level and Monocyte Morphology Predict TLR4 Expression and Reactive Oxygen Species Production Which Influences Chronic Inflammation in β-Thalassemia

Transfusion Complications in Thalassemia: A Report From the Centers for Disease Control and Prevention (CDC)

A Phase 2 Clinical Study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a Fetal Hemoglobin Inducer, in Patients with Sickle Cell Disease

Phase 1/2 Clinical Trial of HQK-1001, An Oral Fetal Hemoglobin Stimulant, In Sickle Cell Anemia

Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia

Emergency Room Utilization by California Sickle Cell Patients During Pediatric to Adult Care Transition

A New Method of Hip Coring Decompression for the Treatment of Femoral Avascular Necrosis In Sickle Cell Disease: Perioperative Safety and Preliminary Efficacy Data

Improved Engraftment without Graft-Versus-Host Disease After MHC-Mismatched Cord Blood Transplantation with Photochemically Treated Donor Lymphocytes.

Rate of Packed Red Blood Cell Transfusion in Pediatric Patients with Severe Chronic Anemia and Normal Cardiopulmonary Status: How Slow Is Truly Necessary?.

Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia.

Prolonged QTc in Sickle Cell Disease: A Potential Risk Factor for Early Death?

Left Ventricular Dysfunction in Chronically Transused Patients with Sickle Cell Anemia and Thalassemia.

MRI Assessment of Pituitary Iron and Volume in Thalassemia, and Relation to Hypothalamic-Pituitary-Gonadal Axis Function (HPG): A Feasibility Study.

Reversive Loss of Pulmonary Function Induced by Acute Chest Syndrome: A Report from the National Acute Chest Syndrome Study Group (NACSG).

Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 2 Year Follow-Up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression.

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only